238 related articles for article (PubMed ID: 4721752)
1. Efficacy of a hookworm (Ancylostoma caninum) vaccine for dogs.
Steves FE; Baker JD; Hein VD; Miller TA
J Am Vet Med Assoc; 1973 Aug; 163(3):231-5. PubMed ID: 4721752
[No Abstract] [Full Text] [Related]
2. Protective immunity against Ancylostoma caninum in dogs vaccinated with free-living soil nematodes.
Abadie SH; Williams JC
Am J Vet Res; 1973 Jan; 34(1):105-8. PubMed ID: 4683965
[No Abstract] [Full Text] [Related]
3. Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs.
Fujiwara RT; Loukas A; Mendez S; Williamson AL; Bueno LL; Wang Y; Samuel A; Zhan B; Bottazzi ME; Hotez PJ; Bethony JM
Vaccine; 2006 Jan; 24(4):501-9. PubMed ID: 16140437
[TBL] [Abstract][Full Text] [Related]
4. Immunity of dogs to ancylostoma braziliense infection following vaccination with X-irradiated Ancylostoma caninum larvae.
Miller TA
J Am Vet Med Assoc; 1967 Mar; 150(5):508-15. PubMed ID: 6068075
[No Abstract] [Full Text] [Related]
5. [Immunity in ancylostomasis. 3. New reports on the immunization of dogs with Ancylostomasis caninum larvae attenuated by U. V. R].
Alvaro Vieira R; Coelho Rombert P
An Inst Hig Med Trop (Lisb); 1974; 2(1-4):485-99. PubMed ID: 4462397
[No Abstract] [Full Text] [Related]
6. Comparison of the immunogenic efficiencies of normal and x-irradiated Ancylostoma caninum larvae in dogs.
Miller TA
J Parasitol; 1966 Jun; 52(3):512-9. PubMed ID: 5942529
[No Abstract] [Full Text] [Related]
7. Protective immunity elicited by ultraviolet-irradiated third-stage infective hookworm (Necator americanus and Ancylostoma caninum) larvae in mice and hamsters.
Jian X; Jun-Min Y; Hai-Chou X; Hui-Qing Q; Hai-Nan R; Hotez P; Bin Z; Shu-Hua X
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):885-95. PubMed ID: 17333729
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms.
Loukas A; Bethony JM; Williamson AL; Goud GN; Mendez S; Zhan B; Hawdon JM; Elena Bottazzi M; Brindley PJ; Hotez PJ
J Infect Dis; 2004 May; 189(10):1952-61. PubMed ID: 15122534
[TBL] [Abstract][Full Text] [Related]
9. Industrial development and field use of the canine hookworm vaccine.
Miller TA
Adv Parasitol; 1978; 16():333-42. PubMed ID: 364958
[No Abstract] [Full Text] [Related]
10. EFFECT OF ROUTE OF ADMINISTRATION OF VACCINE AND CHALLENGE ON THE IMMUNOGENIC EFFICIENCY OF DOUBLE VACCINATION WITH IRRADIATED ANCYLOSTOMA CANINUM LARVAE.
MILLER TA
J Parasitol; 1965 Apr; 51():200-6. PubMed ID: 14275207
[No Abstract] [Full Text] [Related]
11. Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum.
Boag PR; Parsons JC; Presidente PJ; Spithill TW; Sexton JL
Vet Immunol Immunopathol; 2003 Mar; 92(1-2):87-94. PubMed ID: 12628766
[TBL] [Abstract][Full Text] [Related]
12. Effect of age of the dog on immunogenic efficiency of double vaccination with x-irradiated Ancylostoma caninum larvae.
Miller TA
Am J Vet Res; 1965 Nov; 26(115):1383-90. PubMed ID: 5882555
[No Abstract] [Full Text] [Related]
13. Persistence of immunity following double vaccination of pups with x-irradiated Ancylostoma caninum larvae.
Miller TA
J Parasitol; 1965 Oct; 51(5):705-11. PubMed ID: 5857265
[No Abstract] [Full Text] [Related]
14. Control of Ancylostoma caninum in the dog with cthiabendazole.
Ames ER
Am J Vet Res; 1970 Dec; 31(12):2225-31. PubMed ID: 5505148
[No Abstract] [Full Text] [Related]
15. [Effect of various benzimidazole carbamates on somatic larvae of Ancylostoma caninum Ercolani 1859 (Ancylostomidae) and Toxocara canis Werner 1892 (Anisakidae). 3. Immunofluorescent serological studies of antibody levels in treated and untreated dogs].
Petrich J; Stoye M
Zentralbl Veterinarmed B; 1981; 28(4):292-300. PubMed ID: 7027683
[No Abstract] [Full Text] [Related]
16. Antibody-dependent reductions in mouse hookworm burden after vaccination with Ancylostoma caninum secreted protein 1.
Ghosh K; Hotez PJ
J Infect Dis; 1999 Nov; 180(5):1674-81. PubMed ID: 10515831
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylanicum.
Bungiro RD; Greene J; Kruglov E; Cappello M
J Infect Dis; 2001 May; 183(9):1380-7. PubMed ID: 11294670
[TBL] [Abstract][Full Text] [Related]
18. Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae.
Hotez PJ; Ashcom J; Zhan B; Bethony J; Loukas A; Hawdon J; Wang Y; Jin Q; Jones KC; Dobardzic A; Dobardzic R; Bolden J; Essiet I; Brandt W; Russell PK; Zook BC; Howard B; Chacon M
J Parasitol; 2003 Aug; 89(4):853-5. PubMed ID: 14533704
[TBL] [Abstract][Full Text] [Related]
19. A history of hookworm vaccine development.
Schneider B; Jariwala AR; Periago MV; Gazzinelli MF; Bose SN; Hotez PJ; Diemert DJ; Bethony JM
Hum Vaccin; 2011 Nov; 7(11):1234-44. PubMed ID: 22064562
[TBL] [Abstract][Full Text] [Related]
20. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum.
Mendez S; Zhan B; Goud G; Ghosh K; Dobardzic A; Wu W; Liu S; Deumic V; Dobardzic R; Liu Y; Bethony J; Hotez PJ
Vaccine; 2005 May; 23(24):3123-30. PubMed ID: 15837211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
